.jpg)
Practice Innovations
Atypical wounds—including immune-mediated, vasculopathic, malignant, hematologic, metabolic, infectious, dermatologic, and radiation- and envenomation-induced ulcers—are complicated by underlying pathology, tissue fragility, severe pain, and highly variable healing trajectories. Conventional dressings require frequent changes, causing pain and disrupting fragile tissue. Transforming powder dressing (TPD) congeals to form an extended-wear (up to 30 days) conforming, moisture-balancing film that protects the wound and limits disruption, making it well suited for treating atypical wounds.
Our aim was to evaluate real-world outcomes of TPD across a wide range of atypical wound etiologies.
Methods:
A narrative synthesis was conducted using clinical cases of diverse atypical wounds treated with TPD, including vasculitis, pyoderma gangrenosum, calciphylaxis, radiation injury, necrotizing fasciitis, hidradenitis suppurativa, connective tissue disease, lymphangioma, sickle cell disease, spider bite, bullous pemphigoid, and epidermolysis bullosa. Each case incorporated serial clinical assessments documenting healing progression, pain response, and dressing stability.
Results:
Across diverse atypical etiologies, TPD consistently maintained a stable wound environment with minimal disturbance, conformed to irregular surfaces, and facilitated exudate management, granulation and re-epithelialization. Several cases reported meaningful reductions in pain. TPD remained adherent for prolonged periods, even in high-mobility regions, without causing maceration or other adverse reactions.
Discussion:
TPD is a versatile, atraumatic dressing option for atypical wounds, offering stability, moisture balance, low procedural burden, improved patient comfort and strong protection for fragile tissue. These real-world observations support TPD as a valuable adjunct in managing wounds where inflammation, fragility, or pain complicate healing.